2014 Oregon Bioscience Conference, Sept. 15-17

The Oregon Bio 2014 Annual Conference highlights exciting trends and opportunities that are emerging in Oregon’s bioscience community. The overarching mission of the Oregon Bioscience Association is to promote the growth and quality of the bioscience industry in Oregon through community, collaboration and commercialization. The conference will be held at Marylhurst University; the keynote dinner will be at the Collaborative Life Sciences Building.

Conference schedule:

Day One explores Oregon’s best bioscience research and ideas for industry growth, highlighted by keynotes from Thomas Fogarty, M.D. and William Goldstein, Ph.D.

Day Two brings together stakeholders and keynotes who examine recent successes and explore future needs to cultivate a thriving bioscience industry.

Day Three, Biosensor Day, profiles exciting developments shaping the emerging biosensor market, strategies for analyzing biosensor data and efforts driving consumer adoption.

The Oregon Bio 2014 Keynote Dinner promises world class wine tasting, a spectacular setting and keynotes from Brian Druker, M.D. and Sean Robbins.


Project funding available for biomedical commercialization, LOIs due Nov. 12

The Oregon Clinical & Translational Research Institute (OCTRI) is now accepting letters of intent to apply for its Biomedical Innovation Program. The Program cultivates and selects promising translational projects that develop new biomedical devices, diagnostics, and software. Via commercialization from academia to the marketplace, the objective is to move innovative technologies to clinical application, and thus to make a meaningful impact on human health. All applicants are strongly encouraged to take advantage of the Biomedical Innovation Program Q&A discussion led by OCTRI Director, Eric Orwoll, being held October 13th, 2014, from 12pm to 1pm in Mac Hall 1162. Representatives from OCTRI, and Technology Transfer & Business Development will be on hand to answer questions about the program and application process.

Deadline: Letters of intent due November 12, 2014
Amount: Up to $40,000 over one year
Eligibility: Principal investigators must fit OHSU eligibility requirements.

Don’t miss the Biomedical Innovation Program Q&A discussion!
October 13th, 2014, from 12pm to 1pm in Mac Hall 1162.


Critical elements of successful proposals will be a well-developed idea or vision for the end product and a collaboration between clinicians, scientists, and bioengineers; that collaboration will make possible the identification of a significant clinical problem, an innovative idea for a device or diagnostic to address the problem, bioengineering approaches for device or diagnostic development, voice of consumer studies, and early clinical trials.

Learn more about this and other OCTRI funding opportunities.

Enhancing clinical research and subject recruitment: A Partnership Between OHSU and The Vancouver Clinic

The Vancouver Clinic logoOHSU’s Clinical and Translational Research Institute (OCTRI) and The Vancouver Clinic have an established collaboration to improve the success of clinical studies.

The partnership between OHSU and The Vancouver Clinic can provide several advantages for investigators, including:

  1. A large population for expanded recruitment for clinical studies, and expert clinician collaborators.
  2. A large primary and specialty care system for health systems research.
  3. Single, OHSU IRB review for OHSU investigators.

Experience gained by the collaboration has streamlined methods for estimating numbers of eligible patients for clinical studies (via EPIC), developed easier access to project development and costing, and established effective recruitment strategies. For more information on the ways this collaboration can benefit your research and to learn about the process of initiating a potential collaborative project, please contact the OHSU Clinical Research Navigator (Kitt Swartz) at 503-346-3540.


Louis Picker Lab awarded $25 million gift from Gates Foundation

Louis Picker, M.D., and his team have been awarded a $25 million grant from the Bill & Melinda Gates Foundation that will spur their work on a vaccine candidate against HIV.  This work is based on previous findings that this candidate, which uses cytomegalovirus as a vector, can boost effector memory T cells to successfully target simian immunodeficiency virus. This new award will test the safety of a prototype human version of the vaccine in a phase I clinical trial in humans, as well as optimize the vaccine for phase II trials. Read the OHSU media release here, and here’s the Oregonian story.

Applications for American Cancer Society Research Scholar Grants due Oct. 15

Research Scholar Grants are intended to provide support for investigator-initiated projects across the cancer research continuum. These grants provide up to $165,000 per year for up to four years and typically cover the costs of salaries, consumable supplies, and other miscellaneous items required to conduct the proposed research. This funding mechanism supports basic, preclinical, clinical, epidemiological, psychosocial, behavioral research, and research in palliative care and symptom management.

Independent investigators within the first six years of an independent career, within a total of 12 years from the awarding of their terminal degree, and with no more than one R01-type grant are eligible to apply.

Applications are due October 15, 2014

Take a look at other current funding opportunities.

OHSU Researchers at the 2014 Military Health Systems Research Symposium

Eleven OHSU scientists presented to enthusiastic colleagues at the 2014 Military Health System Research Symposium (MHSRS) Aug. 18-21 in Fort Lauderdale, Florida. This unique scientific conference, known for its interdisciplinary subject matter and networking opportunities, is the Department of Defense’s major research meeting to address the medical needs of warfighters. Scientists from academia, industry, and three branches of the military, as well as military clinicians, program heads, and other officials, gather to discuss the latest findings in “military-unique”  research. Topics range widely, including research that addresses the direct results of combat, such as traumatic brain injury diagnosis, hemorrhage control, wound treatment, and rehabilitation, to new developments in regenerative medicine and vaccines to occupational health concerns such as fitness, sleep, and balance. All the research at this conference, however, strives to improve the health and well-being of those in military service.

In 2013,  senior vice president for research Dan Dorsa initiated a program to defray the travel costs for OHSU researchers whose projects are accepted for poster or podium presentations. It’s an opportunity for OHSU faculty to network with scientists from across the world with the eventual goal of fostering productive long-term collaborations and relationships. Last year’s attendees have gone on to form new research collaborations, become peer reviewers for DoD programs, and apply for new funding. This year, presenters included Martin Schreiber, M.D., division chief of Trauma, Critical Care & Acute Surgery in the School of Medicine Department of Surgery; a new faculty member from that division, David Zonies, M.D., associate professor;  and two residents from the same division, Nicole Gordon, M.D., and Alexis Moren, M.D.; Kenton Gregory, M.D., director of the OHSU Center for Regenerative Medicine, and Cynthia Gregory, Ph.D., senior scientist at the OHSU Center for Regenerative Medicine and research scientist at the Portland Veterans Affairs Medical Center; Matthew Butler, Ph.D., assistant scientist, Oregon Institute of Occupational Health Sciences; Laurie King, Ph.D., assistant professor in the School of Medicine Department of Neurology; Paul Cordo, Ph.D., professor, School of Medicine Department of Bioengineering; Kerry Kuehl, M.D., Dr.P.H., professor of medicine and co-director of the Human Performance Laboratory in the School of Medicine Division of Health Promotion & Sports Medicine; and Kathleen Carlson, Ph.D., assistant professor in Public Health and Preventive Medicine and core investigator, PVAMC.

Interested in attending next year? OHSU’s Research Funding and Development Services will be sponsoring a workshop later this academic year to talk about DoD funding in general and this conference in particular.

Anonymous Knight Challenge donor revealed?

We report, you decide.


Practice-Based Research in Oral Health Conference: Addressing Dental Myths and Controversies

OHSU School of Dentistry faculty will present at  “Dental Myths and Controversies VIII,” the theme of the 11th annual Practice-Based Research in Oral Health (PROH) conference, on Oct. 31. Speakers include  Jim Katancik, D.D.S., Ph.D., associate professor and chair of periodontology (Implant Platform Switching: Easy as Taking the Next Train?); Shawneen Gonzalez, D.D.S., M.S., assistant professor in the department of oral pathology and radiology (You see what? Can I Really Interpret that from a Panoramic Radiograph?); Carmem Pfeifer, D.D.S., Ph.D., assistant professor of restorative dentistry (Enhancing Dentin Bond Durability: Is it Really Possible?); Scott Dyer, D.M.D., M.S., Ph.D., adjunct assistant professor of restorative dentistry (It may be Strong, but can I Bond to it? Cementation and Repair of Zirconia); Tom Hilton, D.M.D., M.S., alumni centennial professor in operative dentistry and co-director of the PROH network (Restoration Repair: Do those Patches Really Work?); and Jack Ferracane, Ph.D., chair of restorative dentistry, division director of biomaterials and biomechanics, and co-director of the PROH network (And then you Light Cure. Simple, right?).

 “The PROH conference will address six confusing and contentious dentistry myths facing researchers today,” said Dr. Hilton. “Select faculty from OHSU will introduce their topics, identify the opposing viewpoints, review the relevant research, present their position on the topic based on their understanding of the evidence, and answer questions.”

The conference will be held at the World Trade Center, 121 SW Salmon St., beginning at 7:15 a.m. with a continental breakfast. Register online here; or call (503) 494-8857. SoD students can register for free.


Important NIH updates on genomic data sharing, IACUC review, and biosafety

This week, the National Institutes of Health issued several notices of interest to OHSU researchers. The following is a summary of the agency’s recent announcements:

NIH issues finalized policy on genomic data sharing

The NIH has issued a final NIH Genomic Data Sharing policy. Starting with funding applications submitted for a Jan. 25, 2015, receipt date, the policy will apply to all NIH-funded, large-scale human and nonhuman projects that generate genomic data. If you’re applying, you must state in your cover letter that you will be generating this type of data; applications are now required to include a genomic data sharing plan. Refer to the implementation guidelines to learn more about how this new policy may affect you, and see further comments in Nature.

Changes to IACUC guidance from NIH

The NIH has issued new guidance regarding how you manage IACUC review, clarifying when additional review may be needed–such as when you need to make significant changes to your protocols, e.g. nonsurvival to survival surgery, changes in housing, or alterations of the study objectives–or when changes can be made administratively. Our IACUC leadership is currently weighing the implications of this guidance. Stay tuned, and in the meantime you can read what your colleagues across the U.S. said about this dilemma.

September is National Biosafety Stewardship Month

Your federal agencies care about your safety, and they want you to care too: September is National Biosafety Stewardship Month, a new effort to make sure we don’t expose one another to anthrax or flu or other dangerous things. They are urging all DHHS grantees to participate in this effort and remain vigilant about safety.

Simulation User Network (SUN) Conference at OHSU Sept. 15

SUN Conference

September 15, 2014

Collaborative Life Sciences Building

The Simulation User Network is a collaborative forum put on by OHSU and Laerdal Medical that facilitates user meetings, newsletters and a dedicated website to create, share and apply content specific to patient simulation. Mike Mikkelson, a local Laerdal representative, has extended an invitation to all OHSU faculty, students and staff who may be interested in attending.

Conference Workshops to Include:

  • Debriefing
  • Under My Skin
  • SimPad® Workshop
  • Scenario Potluck
  • Iron Chef! See if you have what it takes to be a Moulage Iron Chef!

For more information, contact:
Mike Mikkelson
, Laerdal Medical Territory Manager, (845) 245-7082
Caitlin Dickinson, OHSU Research Associate, (503) 494-7217

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.